Does estrogen play a role in response to adjuvant bone-targeted therapies?

Bone remains the most common site of breast cancer recurrence. The results of population studies, pre-clinical research and clinical studies in patients with metastatic disease provided a rationale for testing bone-targeted agents in the adjuvant setting. Despite the initial optimism, results from e...

Descripción completa

Detalles Bibliográficos
Autores principales: Russell, Kent, Amir, Eitan, Paterson, Alexander, Josse, Robert, Addison, Christina, Kuchuk, Iryna, Clemons, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723380/
https://www.ncbi.nlm.nih.gov/pubmed/26909288
http://dx.doi.org/10.1016/j.jbo.2013.06.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723380/
https://www.ncbi.nlm.nih.gov/pubmed/26909288
http://dx.doi.org/10.1016/j.jbo.2013.06.001

Ejemplares similares